Follow the investigation into Biolab’s sudden halt to manufacturing in Conyers and the complex finances of its parent, KIK Consumer Products. We connect resident claims and class actions with pressure from creditors and a changing pool chemical market, so you understand how corporate decisions and court rulings could shape health monitoring and compensation for thousands. Join us as we unpack filings, facilities, and the supply chain to reveal what is visible and what remains hidden.

 

This episode opens with host Pamela Kirkland reflecting on how investigative work often looks less like a cloak-and-dagger operation and more like a page-by-page review. That patient approach frames a return to BioLab’s history in Conyers and the earlier corporate bankruptcy that kept resident payouts small. You hear from longtime resident Jean Sadler, who describes missed deadlines, unanswered calls, and her personal costs. You also hear frustration from neighbors who say attorneys have gone quiet while consolidated class actions move slowly.

The focus shifts to how BioLab fits inside KIK Consumer Products and why the Conyers plant once mattered. Former engineer Randy Garcia describes systemic safety issues and explains that Conyers generated significant revenue. Yet industry expert Rudy Stankowitz details why the 2024 fire did not produce a national chlorine shortage. Imports grew, new domestic capacity emerged, and Lake Charles came back online, which made the loss of one site less disruptive.

Finally, we examine the money and the legal risks. Private equity ownership and expensive debt raise the prospect of restructuring. Financial analysts warn about tight liquidity and possible default while KIK names a new chief executive from its finance ranks. At the same time, Georgia’s Supreme Court is being asked whether exposed residents can secure long-term medical monitoring without current symptoms, a question that could shape outcomes for thousands in Conyers. The tape stops with an unsatisfying truth; the most revealing facts are sometimes the gaps in the record.

Tags: Atlanta  Conyers  BioLab  podcast